The former Hoffmann-La Roche Inc. site in Nutley, NJ, was sold in 2016 and is no longer operational. THIS WEBSITE IS ONLY ABOUT THE ENVIRONMENTAL REMEDIATION OF THE FORMER ROCHE NUTLEY SITE.

 

FOR QUESTIONS ABOUT THE ON3 DEVELOPMENT AT THE FORMER ROCHE NUTLEY CAMPUS:
Please contact Prism Capital Partners or call 973-235-3333.

 

FORMER ROCHE NUTLEY EMPLYEES WITH EMPLOYMENT-RELATED INQUIRIES should contact northamerica.askhr@roche.com or call (800) 8166-8221.

 

For all other information, use the following contacts.

ROCHE PHARMACEUTICAL INQUIRIES:
Roche's North American pharmaceutical headquarters is Genentech in South San Francisco
www.gene.com
Genentech Contacts
(800) 626-3553

ROCHE U.S. PRODUCTS:
Genentech
(800) 626-3553

PATIENT QUESTIONS ON MEDICINES:
Patient Resource Center
650-467-0811 or 877-436-3683

PRODUCT MSDS:
Genentech Medicines (for medical professionals)
If you can't locate MSDS, see Genentech Contacts

ROCHE DIAGNOSTICS:
Roche Diagnostics

ROCHE JOBS and OTHER ROCHE INQUIRIES:
Roche Global

NUTLEY SITE ONLY:
Contacts page

NEWS UPDATES

Roche again ranked one of most sustainable healthcare companies in Dow Jones Sustainability Indices: 11th year of recognition

Sustainability is an integral part of the way Roche does business. The Dow Jones reccognition is based on an in-depth analysis of economic, social and environmental performance. See a video of Roche Group CEO Severin Schwan speaking about this 2019 achievement. 
 

Roche Nutley Site Remediation Receives National Honors

TRC Environmental Corporation received top national honors for environmental sustainability in the Roche Nutley Site Remediation project from the American Academy of Environmental Engineers & Scientists (AAEES).  
“TRC’s outstanding dedication and focus have helped us quickly and safely propel our former site into a multi-tenant, first-in-class campus that will benefit the communities and the state of NJ for many generations to come,” noted Tom Lyon, Roche Vice President and former Nutley Site Head.
Shown at the April 24, 2019 awards ceremony in Washington, D.C., are (from left) Rebecca Hollender, TRC Director of LSRP Services; Tom Lyon, Roche Vice President and former Nutley Site Head; Chandra Patel, Roche Nutley Site Environmental Health & Safety Director; Marc Sotsky, Roche Nutley Finance Head; Dawn Pompeo, TRC Vice President and Ken Seit, TRC Vice President. 
For more information, see AAEES press release.

 

Seton Hall Magazine's Fall 2018 issue features words from Interrim University President Mary Meehan, Ph.D, about the new Interprofessional Health Campus on the former Roche-Nutley site and what it means to the University, its students, and most importantly, "the ways in which Seton Hall’s future doctors, nurses and other health professionals will improve the world as servant healers." 

_____________

Nutley Site Sold to PB Nutclif I, LLC, an affiliate of locally-based Prism Capital Partners, LLC (Prism)

On September 29, 2016, Roche completed the sale of its 116-acre campus, located in the Township of Nutley and City of Clifton, New Jersey, to PB Nutclif I, LLC, an affiliate of locally-based Prism Capital Partners, LLC (Prism). For more information on the future of the former Roche site, please see the July 14, 2016 news release or contact Prism at 201-567-2711 or 973-562-9580, www.prismpartners.net.

Roche retains responsibility for the environmental cleanup of the site. A dedicated Roche team is working under the oversight of the New Jersey Department of Environmental Protection (NJDEP). The company has completed soil remediation field work on the property and has several interim remedial measures underway for groundwater cleanup while longer-range plans are developed for site-wide groundwater remediation. 

Site to include new medical school

Seton Hall University and Hackensack Meridian Health entered into a long-term lease with Prism Capital Partners to lease two major R&D buildings and 16 acres on the site. The lease enables Hackensack Meridian Health and Seton Hall University to move forward with their plans for a private medical school and a world-leading National Health Institute-designated Clinical Research Center on the former Roche campus. Seton Hall also plans to co-locate its College of Nursing and School of Health and Medical Sciences with the new School of Medicine. For more information on the medical school, see the HUMC news release. Also, view a HUMC video that highlights plans for the new facility.

REMEDIATION UPDATES

SIX MONTH UPDATE: 
Roche Report to the Community provides highlights of the Roche Nutley Environmental Remediation covering the period from May 23 - Nov. 21, 2019.

GROUNDWATER IRM PROGRESS REPORTS TO NJDEP: Reports and letters submitted for Interim Remedial Measures [IRMs] undertaken in the following Investigative Areas (IAs): IA-1/4, IA-1/Building 55, IA-2, IA-6, IA-3/7, IA-7/South, IA-9, IA-10/Building 70, IA-10/former Building 104 area, IA-12 and IA-12/IO-2. See GW IRM Page: April 2019

GROUNDWATER RAWP TO NJDEP: Groundwater Remedial Action Work Plan, submitted to NJDEP Feb. 15, 2019. NOTE:  depending on your screen setting, you may have to scroll to the right to see the pages.

GROUNDWATER PROGRESS REPORT TO NJDEP: Site-wide Groundwater Progress Reportsubmitted to NJDEP Feb. 22, 2019, reflects data from August 2017 to April 2018. See Groundwater Update - Feb. 2019 for supporting documents.

For other remediation sumbissions/documents, see Remediation Updates.

PLEASE NOTE: All documents and reports submitted to the New Jersey Department of Environmental Protection (NJDEP) for the environmental investigation and remediation of the former Roche Nutley site are also available through NJDEP at  http://www.nj.gov/dep/opra/

Contacts

FOR NUTLEY SITE REMEDIATION:
Roche Nutley
800 Bloomfield Ave.
Suite 127
Nutley, NJ 07110-3202
Telephone (for remediation only):
(908) 988-1731 

ALL ON3 DEVELOPMENT INQUIRES:
www.prismpartners.net
(973) 235-3333

ALL FORMER EMPLOYEE INQUIRIES:
northamerica.askhr@roche.com

ROCHE PHARMACEUTICAL INQUIRIES:
www.gene.com    Genentech Contacts
(800) 626-3553

ALL OTHER:
Key Contacts